GlassScriptPhysician profile
Scott D Dudak
NPI 1831139351
$3,211.68
in general payments reported to CMS, 2019-2025
23 companies · $47.07 in 2025
The $47.07 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $240 · 2021: $553 · 2022: $1,367 · 2023: $269 · 2024: $166 · 2025: $47.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346 · Debt Forgiveness: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.60 |
| Debt Forgiveness | $136.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $943.02 | 2021-2022 | |
| Janssen Biotech, INC. | $894.28 | 2019-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $199.89 | 2021-2023 | |
| Abbvie INC. | $158.72 | 2019-2022 | |
| Urogen Pharma, INC. | $141.01 | 2021 | |
| Olympus America INC. | $136.55 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $124.94 | 2022 | |
| Astellas Pharma US INC | $121.58 | 2019 | |
| Axonics, INC. | $116.63 | 2021 | |
| Antares Pharma, INC. | $49.20 | 2019-2025 | Xyosted |
| Focal Therapeutics, INC. | $38.29 | 2019 | |
| Myriad Genetic Laboratories, INC. | $36.48 | 2022 | |
| Tactile Systems Technology INC | $35.31 | 2019 | |
| Conmed Corporation | $34.14 | 2020 | |
| Progenics Pharmaceuticals, INC. | $29.33 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $29.10 | 2021 | |
| Urovant Sciences INC | $23.93 | 2022 | |
| Hologic INC | $23.55 | 2022 | |
| Laborie Medical Technologies Corp. | $20.58 | 2022 | |
| Photocure INC | $15.78 | 2025 | Cysview |
| Merck Sharp & Dohme LLC | $15.34 | 2025 | Keytruda |
| Avadel Specialty Pharmaceuticals, LLC | $12.17 | 2019 | |
| Procept Biorobotics Corporation | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Dudak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.